Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Testing Oxygen Levels During Anaesthesia for Non-cardiac Surgery

Tests how high oxygen levels affect heart function in adults having surgery under general anaesthesia.

Plain-language title generated from the registry record
Registry title: Influence of Oxygen on Perioperative Outcome in Patients Undergoing General Anaesthesia for Elective Non-cardiac Surgery

Key facts

Where
Bern, SwitzerlandSee the site

Where in Switzerland

  • Bern University Hospital, InselspitalBern, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Insel Gruppe AG, University Hospital Bern
Trial code
NCT04808401
Record updated
13 December 2024
Original description
The purpose of this study is to investigate the impact of supraphysiologic oxygen (hyperoxia) on myocardial function in anaesthetized patients undergoing non-cardiac vascular surgery.Read full original descriptionShow less

Influence of Different Inspired Oxygen Fractions on Perioperative Myocardial Biomarkers, Myocardial Strain and Outcome in Patients Undergoing General Anaesthesia for Elective Non-cardiac Surgery: A Prospective Randomized Open-label Single Centre Pilot Study

The purpose of this study is to investigate the impact of supraphysiologic oxygen (hyperoxia) on myocardial function in anaesthetized patients undergoing non-cardiac vascular surgery.

Inclusion: Written informed consent; Patients eligible for the study should be scheduled for elective or non-emergent non-cardiac vascular surgery under general anaesthesia with endotracheal intubation, and have either; proven CAD and will undergo high- or intermediate surgical risk procedure according to European (European Society of Cardiology, ESC / European Society of Anaesthesiology and Intensive Care, ESAIC) guidelines on non-cardiac surgery; or; two or more risk factors for CAD and will undergo high- or intermediate surgical risk procedures according to European ESC/ESAIC guidelines on non-cardiac surgery.

Exclusion: Acute coronary event 30 days before surgery; Hemodynamic instability before induction of aneasthesia (vasopressor or inotrope infusion since hospitalization for index surgery); Scheduled surgery in the thoracic cavity; Emergency surgery (to be performed within less than 12 hours of scheduling); Ambulatory surgery; Acute congestive heart failure; Atrial fibrillation or other severe arrhythmia; Severe pulmonary disease (dependent on oxygen therapy or the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 4 or severe carbon monoxide diffusion impairment or severe pulmonary hypertension); Increased risk of oxygen toxicity (e.g., chemotherapy for malignancy within 3 months, bleomycin treatment, airway laser surgery); Pre-existing surgical site infection (SSI); Current active signs of systemic inflammatory response syndrome (SIRS) or sepsis according The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3); Preoperative oxygen saturation (SpO2) below 90% on room air; ICU admission for respirator weaning and delayed extubation; Pregnancy; Baseline hs-TnT level elevated above 65ng/L.

ClinicalTrials.gov NCT04808401